Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: Year-End Submissions Rush Brings Seven Novel Agents To US FDA

06 Jan 2020

• By Bridget Silverman

Related Content

Keeping Track: A Novel Approval For Fluorodopa F 18, A Tentative Approval For Vumerity, And A Missed Goal Date For Zilretta

20 Oct 2019

Keeping Track: Industry Beefs Up 2020 Review Pipeline With Submissions Galore

04 Nov 2019

Clear Path For AstraZeneca’s Roxadustat After Reassuring Safety Data

11 Nov 2019

Hemophilia A Gene Therapy: BioMarin In Lead, Sangamo ‘Prays’ For Superior Results

22 Nov 2019

Gene Therapy 'Vant' Unveiled As Dainippon, Roivant Finalize $3bn Deal

06 Nov 2019

Data For Two HER2-Positive Breast Cancer Drugs Impress, Including On Overall Survival

12 Dec 2019

China’s Luye Pursues Global Differentiation Strategy

30 Aug 2019

Related Companies

MorphoSys AG

Seagen Inc.

Eli Lilly and Company

Loxo Oncology at Lilly

BioMarin Pharmaceutical Inc.

Roivant Sciences Ltd.

Urovant Sciences, Inc.

Luye Pharma Group, Ltd.

FibroGen, Inc.

AstraZeneca PLC

Additional Topics

United States Drug Review Review Pathway Regulation US FDA Performance Tracker BioPharmaceutical Cancer Neurology Blood & Coagulation Disorders

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.